The VELscope System Plays an Important Role in the Fight to Reduce Oral Cancer Mortality and Morbidity According to the SEER database:
• Found early, oral cancer’s five-year
survival rate is 80% to 85%
• Found late, oral cancer’s five-year survival rate is only about 50%.
The VELscope® Vx, the latest model release of LED
Dental’s VELscope technology, uses natural tissue
fluorescence to discover abnormalities in the oral
mucosa. The VELscope is an extremely effective aid
for discovering and defining the extent of a wide
range of mucosal abnormalities, including oral
cancer. Importantly, VELscope helps you discover
problems before they can be seen under
ordinary white-light conditions.
Unfortunately, oral cancer is often
discovered in the late stages when
the prognosis for the patient is poor. Used in conjunction with the conventional
intra- and extra-oral exam,
VELscope provides visual information
that cannot be acquired in any other way,
and helps discover problems that may
not be apparent to the naked eye.
